Literature DB >> 15580461

[Acute renal failure].

M Krych1.   

Abstract

The acute renal failure is characterized by a rapid deterioration of the renal function. In addition to the usual prerenal, intrinsic and postrenal causes of an acute renal failure distinct causes have to be considered for oncological patients. Factors imminent to the malignant disease, e. g. paraneoplastic syndromes or retroperitoneal bulks can account for an acute renal failure. Paraproteins as produced by a multiple myeloma are other possible causes for renal dysfunction. For some anticancer drugs nephrotoxicity is a potential side effect, in particular for cisplatin, methotrexate, ifosfamide and melphalan. A hemolytic uremic syndrome may be induced by mitomycin and gemcitabine. Extensive surgery can be associated with rhabdomyolysis and myoglobinuria and results in renal impairment. Treatment of a chemosensitive neoplasia with a highly effective regimen may result in a tumor lysis syndrome with hyperuricemia, hyperkalemia, hyperphosphatemia and hypocalcemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15580461     DOI: 10.1007/s00108-004-1316-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

Review 1.  [Acute kidney failure].

Authors:  A Jörres; U Frei
Journal:  Internist (Berl)       Date:  2001-03       Impact factor: 0.743

2.  Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.

Authors:  C-K Lee; M Zangari; B Barlogie; A Fassas; F van Rhee; R Thertulien; G Talamo; F Muwalla; E Anaissie; K Hollmig; G Tricot
Journal:  Bone Marrow Transplant       Date:  2004-04       Impact factor: 5.483

3.  Alkalinization and the tumor lysis syndrome.

Authors:  A D Ten Harkel; J E Kist-Van Holthe; M Van Weel; M M Van der Vorst
Journal:  Med Pediatr Oncol       Date:  1998-07

Review 4.  Acute renal failure due to rhabdomyolysis associated with radical perineal prostatectomy.

Authors:  E Orihuela; T Nazemi; T Shu
Journal:  Eur Urol       Date:  2001-05       Impact factor: 20.096

Review 5.  Malignancy and renal disease.

Authors:  M Kapoor; G Z Chan
Journal:  Crit Care Clin       Date:  2001-07       Impact factor: 3.598

6.  The role of circulating immune complexes and biocompatibility of staphylococcal protein A immunoadsorption in mitomycin C-induced hemolytic uremic syndrome.

Authors:  Bipinchandra Mistry; Paul L Kimmel; Paul C Hetzel; Terence M Phillips; Gregory L Braden
Journal:  Am J Kidney Dis       Date:  2004-10       Impact factor: 8.860

7.  Low urine osmolarity as a determinant of cisplatin-induced nephrotoxicity.

Authors:  Emmanuel Polycarpe; Laurent Arnould; Elise Schmitt; Laurence Duvillard; Emmanuelle Ferrant; Nicolas Isambert; Christian Duvillard; Jean-Luc Beltramo; Dominique Chevet; Bruno Chauffert
Journal:  Int J Cancer       Date:  2004-08-10       Impact factor: 7.396

Review 8.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

9.  Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.

Authors:  A Kedar; W Grow; R E Neiberger
Journal:  Pediatr Hematol Oncol       Date:  1995 Mar-Apr       Impact factor: 1.969

Review 10.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.